Stay updated with breaking news from Douglasw loe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Douglas W. Loe, analyst for Leede Jones Gable, reviewed the latest news from Theratechnologies in an update to clients on Monday and reiterated a “Speculative Buy” rating on the stock. ....
In an update to clients on Monday, Leede Jones Gable analyst Douglas Loe reiterated a “Buy” rating on Profound Medical while upping his target price to $18. ....
Leede Jones Gable analyst Douglas W. Loe provided an update to clients on ProMIS Neurosciences on Monday where he reiterated a Speculative Buy rating on the stock. ....